Urothelial Cancer
JZP898-101: A Phase 1, first-in-human, open-label, multicenter study of JZP898 as monotherapy and in combination with pembrolizumab in participants with advanced or metastatic solid tumors
- Details
ClinicalTrials.gov ID:
NCT06108050
Diagnosis Type:
NA
USOR Number:
- Address
,
P: